¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷ : 2023-09-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷ : 2023-09-21
±³À°ÀÏÀÚ : 2023-09-21
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º ±×·£µåº¼·ë

±³À°ÁÖÁ¦ : 2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ

´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335

À̸ÞÀÏ : kshf3@kshf.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í [»çÀüµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 70,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 30,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 10,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á [ÇöÀåµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 80,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 40,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 20,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:20~10:35 Current Issues of Heart Failure in Korea - What's New from KorHFIII Registry? Á¶ÇöÀç(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:35~10:50 HF Epidemiology in Asia-Pacific Region Compared to Other Regions Jing Yu(Lanzhou University Second Hospital)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:50~11:05 Considerations for the Diagnosis of HF in the Asia-Pacific Region - Present and Future Yasuhiko Sakata(National Cerebral and Cardiovascular Center)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:05~11:20 Considerations for the Treatment of HF in the Asia-Pacific Region - Present and Future Nancy K. Sweitzer(Washington University School of Medicine)

Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:20~11:40 Discussion ±è¼Ò¸® ±èÀÎö ¼ÕÁ¤¿ì ÃÖÁø¿À(°í·ÁÀÇ´ë °è¸íÀÇ´ë ¿¬¼¼¿øÁÖÀÇ´ë ¼º±Õ°üÀÇ´ë)

½Ä»ç 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:40~12:40 Lunch ( )

±âŸ 09¿ù 21ÀÏ ±×·£µåº¼·ë 12:40~13:00 Opening Ceremony ( )

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:00~13:15 Biomarker-driven prognostic models in chronic HFpEF Andrew Coats(Heart Research Institute)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:15~13:30 The role and limitations of natriuretic peptides in contemporary landmark trials À¯º´¼ö(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:30~13:45 The different pathophysiology between HFrEF and HFpEF ±è´Ù·¡(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:45~14:00 The role of long non-coding RNAs detecting myocardial fibrosis ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)

Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:00~14:20 Discussion Á¶µ¿Çõ ¹ÚÈÆÁØ È²¼®Àç(°í·ÁÀÇ´ë °¡Å縯ÀÇ´ë °æ»óÀÇ´ë)

ÈÞ½Ä 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:20~14:40 Break ( )

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:40~14:55 HCM_diagnosis and risk stratification ÃÖÀÇ¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:55~15:10 HCM_current treatment strategy and future perspectives Yuya Matsue(Juntendo Univ.)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:10~15:25 HCM_surgical treatment Á¤¼ºÈ£(¿ï»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:25~15:40 Genetics in HCM ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)

Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:40~16:00 Discussion ÃÖÀÚ¿¬ ¹Ú¿¹¹Î ÀÌÇöÁ¤ Á¤Çý¹®(°í·ÁÀÇ´ë °¡ÃµÀÇ´ë ¿¬¼¼ÀÇ´ë °æÈñÀÇ´ë)

ÈÞ½Ä 09¿ù 21ÀÏ ±×·£µåº¼·ë 16:00~16:30 Break ( )

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 16:30~17:00 Key inflammatory mechanisms and IL-6 in Heart Failure Adriaan A. Voors(University Medical Center Groningen)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:00~17:15 Review of trials of anti-inflammatory treatment in Heart Failure ±è¹Î¼®(¿ï»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:15~17:30 Sarcoidosis: Focus on antiInflammatory management Yuya Matsue(Juntendo Univ.)

Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:30~17:50 Discussion ÀÌÁøÈ­ ±èÀÎö ÀÌÂùÁÖ Á¶À翵(ÇѸ²ÀÇ´ë °è¸íÀÇ´ë ¿¬¼¼ÀÇ´ë Àü³²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷ : 2023-09-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) »ó±Þº´¿øÀ¸·Î ÀÇ·Ú°¡ ÇÊ¿äÇÑ µÎ°æºÎÁúȯ : 2023-09-21
´ÙÀ½±Û ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ¿µ³²ÁöºÎ 2023³â 9¿ù Áý´ãȸ : 2023-09-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 47 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷